Skip to main navigation Skip to search Skip to main content

Safety Analyses of the Phase 3 VISION Trial of [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer

  • Kim N. Chi
  • , Andrew J. Armstrong
  • , Bernd J. Krause
  • , Ken Herrmann
  • , Kambiz Rahbar
  • , Johann S. de Bono
  • , Nabil Adra
  • , Rohan Garje
  • , Jeff M. Michalski
  • , Mette M. Kempel
  • , Karim Fizazi
  • , Michael J. Morris
  • , Oliver Sartor
  • , Marcia Brackman
  • , Michelle DeSilvio
  • , Celine Wilke
  • , Geoffrey Holder
  • , Scott T. Tagawa

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Safety Analyses of the Phase 3 VISION Trial of [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science